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ABSTRACT 
 
Post-mortem data on chronic alcohol abuse can be difficult to obtain due to 
putrefaction, inadequate background information at time of autopsy, and 
lack of distinctive pathological characteristics. However, diagnosis of 
chronic alcohol abuse can aid in death investigations and assist in 
establishing the cause and the manner of death. A well established 
biomarker of chronic alcohol abuse is Carbohydrate-Deficient Transferrin 
(CDT) (Bortolotti, 2006). Transferrin (Tf) is an iron transport serum 
glycoprotein consisting of two oligosaccharide chains. CDT is a subset of 
hypoglycosylated isoforms typically losing one or both glycan chains. 
Consuming 50-80 grams of alcohol a day for at least 7 days increases CDT 
serum values. After abstinence CDT returns to normal values in about 2-3 
weeks. According to a sound body of literature, the diagnostic sensitivity of 
this marker ranges from 70-80%, while diagnostic specificity is about 100%. 
CDT value is expressed as percentage ratio of total transferrin; in non 
alcohol abusers being below 1.8% (Delanghe, 2009). Notwithstanding CDT 
is a worldwide recognized marker of chronic alcohol abuse, few studies are 
published on post-mortem applications largely because of the analytical 
problems caused by the post-mortem blood. The aim of this work was to 
investigate the possible use of this marker in post-mortem cases, 
developing an analytical method based on capillary zone electrophoresis 
suitable for the analysis of post-mortem samples. 
498 post-mortem blood samples from the Office of the Chief Medical 
Examiner (OCME) in Connecticut were obtained with no restrictions. 
Measurement of CDT was done by capillary zone electrophoresis using a 
Beckman Coulter ProteomeLab PA 800 using a UV detector at 200 nm in the 
forward direction. All data was analyzed using 32 Karat software version 
7.0.   
Of the 498 samples, only 72 samples resulted in interpretable 
electropherograms. CDT value in these samples ranged from 0.43-13.04% 
(average 2.39%, SD 2.49%). 27 subjects showed CDT values higher than the 
established cut-off of 1.8% (used to distinguish between normal subjects 
and alcohol abusers) suggesting a condition of chronic alcohol abuse. Of the 
30 cases with anatomo-pathological findings consistent with chronic 
alcohol abuse, 16 also had an increased %CDT. Moreover, 24 subjects 
indicated a recent alcohol intake as demonstrated by the determination of 
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blood alcohol content (BAC) (range 0.03-0.41%). Of these subjects, 18 were 
above the legal limit of 0.08%. 
Capillary zone electrophoresis of post-mortem samples was useful in 
evaluating CDT to determine chronic alcohol abuse in autopsy cases. 
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INTRODUCTION 
 
Consuming alcoholic beverages in a social setting has long been considered 
a way to relax and enjoy visiting with family and friends and has even been 
shown in some forms to help prevent cardiovascular disease in individuals. 
Alcohol, more specifically ethanol, has been a part of social gatherings for 
centuries helping to celebrate and commiserate. While ethanol itself is not 
an illegal substance it is understood that limits must be in place for certain 
activities while under the influence, above which the activity is illegal to 
perform (e.g. drive). These legal levels were created to reduce risky 
behaviors associated with increased amounts of inebriation leading to 
reduced cognitive ability and motor skills, lowered inhibition, and 
sleepiness among other characteristics.  
Even though risks are associated with consuming high levels of ethanol, 
especially for long periods of time, many people still participate in the 
activity. As of 2009 in the United States of America (USA) according to the 
Centers for Disease Control and Prevention (CDC, 2009)  13.8 million adults 
abused alcohol, 8.1 million being alcoholics. Men are three times more 
likely to abuse alcohol than women and alcohol has been determined as 
the third leading preventable cause of death in the USA due to the 
approximate 79,000 deaths that occur every year.  
As abuse of this readily available substance continues it is important to 
determine reliable ways to test individuals. Biochemical tests are 
performed routinely in drug screens due to the high usage of alcohol in 
society. Testing of individuals involved in high risk jobs or who are not 
permitted to consume alcohol while working is a valuable tool. Such jobs 
include ones utilizing heavy machinery, driving, aviation, and construction. 
Increases in biomarkers such as Gamma-glutamyl Transferase (GGT), 
Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), and 
mean corpuscular volume (MCV) signify liver damage which can be 
indicative but not limited to alcohol abuse. The markers are used widely in 
the clinical setting and are useful in first establishing a possible abuse 
pattern as the tests tend to be lower in cost and quick to complete. 
Monitoring and testing of living individuals has become routine but a void 
remains in the post-mortem area of chronic alcohol detection. Alcohol 
abuse is directly and indirectly associated with deaths (suicides, homicides, 
accidents) and can help medical examiners and medico-legal investigators 
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ascertain a decedent’s behavior leading up to the incident. A negative 
blood alcohol concentration (BAC) at time of death does not necessarily 
mean that alcohol was not consumed on a regular basis before death, 
rather that it was not consumed close enough to the time of death and has 
had time to metabolize. Conversely, a positive BAC does not immediately 
deem the decedent a chronic alcohol abuser and this fact could be 
important to determine in an investigation. Moreover at time, there are 
often no conclusive pathological findings for chronic alcohol abuse as well 
as a lack of amnestic data for the medical examiner to pull data from. For 
these reasons a reliable method for CDT quantification in post-mortem 
samples would provide professionals a tool with which to determine 
chronic alcohol abuse ante-mortem. 
 
ALCOHOL AND ALCOHOL ABUSE 
 
Alcohol is consumed for a variety of reasons ranging from benign and 
extending to harmful excess. A typical drink is defined by any alcoholic 
beverage containing 14 g of ethanol (0.6 fl ounces), e.g. a 12 ounce beer 
(354 mLs), 5 ounces of wine (148 mLs), or 1.5 ounces of hard alcohol (44 
mLs) (NIAAA, 2011). Alcohol usage comes in many forms such as abstainers 
(teetotalers), binge drinkers, moderate, and chronic. While abstainers of 
alcohol are clear, binge drinkers are defined as having 5 or more drinks in a 
period usually one hour or within two hours elevating their blood alcohol 
concentration above 0.8 (80 mg/dL). Acute intoxication of alcohol occurs 
when the consumption of alcohol exceeds the body’s ability to metabolize 
and it continually circulates through the bloodstream and tissues until it is 
excreted. Chronic alcohol abuse typically results from the consumption of 
50-80 g of ethanol daily for an extended period of time and can lead to far 
reaching physical and psychological damage. 
Since alcohol is one of the most abused legal drugs it is important to 
understand its clinical classifications of abuse and dependence. The 
American Psychiatric Association’s DSM-5, updated as of November 2013 
(NIAAA, 2013), has combined the previously separate alcohol abuse and 
alcohol dependency (DSM-IV) into one disorder known as alcohol use 
disorder (AUD). AUD has three sub classifications entitled mild, moderate, 
and severe. Under this new system anyone who experienced two of the 
eleven criteria in a twelve month period are said to have AUD, the severity 
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further determined by the total criteria associated with the individual. The 
eleven criteria determined for evaluation of AUD are as follows: 
 
 Alcohol is often taken in larger amounts or over a longer period than 
was intended. 
 There is a persistent desire or unsuccessful efforts to cut down or 
control alcohol use. 
 A great deal of time is spent in activities necessary to obtain alcohol, 
use alcohol, or recover from its effects. 
 Craving, or a strong desire or urge to use alcohol. 
 Recurrent alcohol use resulting in a failure to fulfill major role 
obligations at work, school, or home. 
 Continued alcohol use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of 
alcohol. 
 Important social, occupational, or recreational activities are given up 
or reduced because of alcohol use. 
 Recurrent alcohol use in situations in which it is physically hazardous. 
 Alcohol use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have 
been caused or exacerbated by alcohol. 
 Tolerance, as defined by either of the following: 
o A need for markedly increased amounts of alcohol to achieve 
intoxication or desired effect 
o A markedly diminished effect with continued use of the same 
amount of alcohol 
 Withdrawal, as manifested by either of the following: 
o The characteristic withdrawal syndrome for alcohol  
o Alcohol (or a closely related substance, such as a 
benzodiazepine) is taken to relieve or avoid withdrawal 
symptoms.  
 
Alcohol dependence is clearly a more involved disease as the persons 
affected relinquish normal behaviors in the pursuit of their addiction. 
Alcohol abuse can be both acute and chronic; however, alcohol 
dependence results from habitual abuse of alcohol. 
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Determining alcohol abuse is of great interest in the forensic science field 
as it is often the precursor to many crimes and accidents. Alcohol plays 
important roles in many forensically relevant cases such as fatal motor 
vehicle accidents, workplace injuries, child placement, drowning, 
homicides, and suicides. Being able to understand and interpret both 
analytical results and psychological issues regarding alcohol abuse are 
integral to understanding actions and reasons associated with casework. 
 
ALCOHOL METABOLISM 
 
Ethanol is a small water soluble molecule that easily diffuses across all 
membranes and causes harmful effects in cells due to its ability to interfere 
with proteins and membrane structures. There are several metabolic 
pathways for the removal of alcohol from the body the main one being 
oxidative metabolism via hepatocytes (liver cells) with minor oxidative 
pathways utilizing catalase and cytochrome p450 as well as non-oxidative 
pathways such as those that form ethyl glucuronide (EtG), ethyl sulfate 
(EtS), phosphatidylethanol (PEth), and fatty acid ethyl esters (FAEEs). The 
majority of alcohol is metabolized in a two stage oxidative pathway (phase 
I) converting the alcohol to acetaldehyde via alcohol dehydrogenase then 
forming acetic acid by converting the acetaldehyde utilizing aldehyde 
dehydrogenase. A much smaller percentage of alcohol undergoes phase II 
glucuronidation or sulfate conjugation of ethanol. A percentage of the 
alcohol (~10%) is also excreted unchanged through the urine, sweat, and 
expired breath of the consumer. 
First pass metabolism (FPM) is done predominately in the stomach with 
second pass metabolism (SPM) taking place in the liver, the majority of 
absorption occurring in the small intestine with alcohol being carried to the 
liver via veins from the stomach and bowels as well as the portal vein. Once 
the alcohol enters the liver the primary pathway of oxidative metabolism 
can start. The ethanol reacts with alcohol dehydrogenase (ALD) present in 
the cytosol and becomes acetaldehyde which is a toxic and highly reactive 
substance. In order to remove the acetaldehyde, aldehyde dehydrogenase 
(ALDH) reacts and forms acetate which leaves the liver and travels to the 
blood where it is further metabolized to carbon dioxide and water, then 
excreted (Zakhari, 2006).  
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Alcohol that is present in cells where there is no ALD or low levels of the 
enzyme such as brain and muscle cells use cytochrome p450 and catalase 
to eliminate the alcohol.  
 
 
BIOLOGICAL MARKERS OF ETHANOL CONSUMPTION 
 
Due to the far reaching health and societal effects of alcohol it is important 
to be able to measure alcohol levels in persons for various reasons. The 
many tests used to determine alcohol usage in persons are considered 
state markers while the enzyme content and genetic code for various 
proteins involved in alcohol metabolism are considered trait markers. Trait 
markers can indicate predispositions for alcoholism, higher levels of 
intoxication, or increased behavioral sensitivity to the consumption of 
alcohol (Jones, 2008). Some trait markers include mutations in alcohol 
dehydrogenase that increase the enzymatic rate of metabolism leading to 
more damage by acetalaldehyde due to rate limiting at the acetaldehyde 
dehydrogenase step. Levels of the neurotransmitter GABA present is 
another trait marker that is inherited, and studies have found that alcohol 
abusers have lower levels of than abstainers, indicating at least a tentative 
link with between GABA and chronic alcoholics (Peterson, 2004). 
State markers depend on the consumption of alcohol, increasing with 
heavier use and decreasing with abstention. In forensic science, state 
markers test persons for acute and chronic intoxication in traffic violations, 
custody hearings, workplace fitness testing, motor vehicle homicides, 
suicides, and accidental deaths among other cases. State markers are used 
to determine fault, behavior before death or crime, fitness for placing a 
child, and monitoring levels for license reissuing (Bortolotti 2011). It can be 
important to make the distinction between an acute intoxication and a 
chronic abuse of alcohol, the latter more indicative of a person who will 
likely repeat their behavior. There are several state markers that can be 
used to test for acute and chronic alcohol abuse. 
 
MARKERS OF ALCOHOL ABUSE 
 
ALCOHOL & COGENERS 
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The most common chemical marker of acute intoxication is the direct 
measurement of ethyl alcohol (ethanol) itself in the blood and/or breath. 
Ethanol remains in the body for up to 24 hours in expired air, blood, and 
urine and indicates a recent consumption of alcohol but cannot decipher 
whether chronic or a binge event. Blood alcohol content (BAC) 
measurement of blood is the more reliable form of direct ethanol testing 
but can be more difficult since the blood must be taken by a professional 
(usually at a hospital) and not in the field. BAC is commonly determined by 
head space sampling gas chromatography utilizing a flame ionization 
detector (HS-GC).  
A breath test can be performed in the field along with sobriety testing but 
has more variability depending on the respirations of the subject. This is a 
non invasive and easy test that allows for fast measurement of alcohol 
consumption. Most breath analyzers (breathalyzers) are designed using an 
average blood breath ratio (BBR) of 1:2100 for comparison of alcohol 
between the breath and blood partition.  
Methanol is found in alcoholic beverages in concentrations of 0.1% (vodka) 
to 2% (brandies). An elevated level of methanol in blood (> 0.01 g/dL) can 
be indicative of chronic alcoholism (Jones 2008). It is also important to note 
that trace levels of ethanol and methanol are produced naturally in the 
body, especially during decomposition via bacterial action and are not 
necessarily indicative of alcohol consumption. An increased amount of 
alcohol use will lead to elevated levels of methanol in the blood and can be 
indicative of abuse. 
 
METABOLITES OF ETHANOL  
 
ACETALDEHYDE 
 
Acetaldehyde is a direct metabolite of ethanol resulting from its reaction 
with alcohol dehydrogenase (ADH) and is quickly further metabolized to 
acetic acid by aldehyde dehydrogenase (ALD). After consumption of alcohol 
the levels of acetylaldehyde increase and can be measured. Genetic traits 
such as a mutant ALD2 gene found in asian populations can cause high 
levels of acetaldehyde to accumulate in blood as a result of poor binding to 
its substrate. The resulting levels of acetylaldehyde cause negative 
symptoms within the individual such as nausea, difficulty breathing, 
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tachycardia, and flushing  (Jones, 2008). Those with the ALD2 gene 
mutation are intolerant to alcohol and medications that inhibit ALD2 have 
been used as aversion therapy to treat chronic alcoholics. 
 
ETHYL GLUCURONIDE (EtG) & ETHYL SULFATE (EtS) 
 
Ethyl glucuronide (EtG) and ethyl sulfate (EtS) are direct metabolites 
formed after ethanol undergoes glucuronidation or sulfate conjugation 
following ethanol consumption and can be detected in blood, urine, and 
hair after consuming alcohol. EtG is formed by conjugating glucuronic acid 
to ethanol via catalysis by UDP-glucuronylsyltranferase while EtS is a 
conjugation between ethanol and sulfate catalyzed by sulfotransferase. 
Schmitt reported detection of EtG in serum up to 8 hrs after elimination of 
ethanol (Schmitt 1997). Halter reported that EtG and EtS can be detected in 
urine for days (three to eight times longer than ethanol) after ethanol 
consumption depending on initial dose (Halter 2008). Due to the shorter 
detection of EtG in serum and the longer detection of EtG and EtS in urine 
they present a way to determine both recent use of alcohol and an 
intermediate use bridging the short term marker of ethanol and the typical 
long term markers such as MCV, γGT, and CDT. In addition the short half life 
of EtG and EtS of 2-3 hours allows for these markers to be used for 
monitoring abstinence from alcohol use before and after surgery where 
alcohol use is prohibited. False positive of determination of EtG and EtS in 
urine have been attributed to ethanol containing mouthwashes and hand 
sanitizers among others.  
Ethyl glucuronide has been determined as a marker for chronic alcohol 
abuse when measured in hair. The Society of Hair testing (SoHT) 
established guidelines for the determination of EtG in hair samples, citing a 
proposed cut-off value of 30 pg/mg to distinguish between use and abuse 
(Kintz, 2010). However the diagnostic specificity and sensitivity of hair EtG 
are scarcely known with variability in sweating patterns and hygiene 
affecting EtG concentrations (Tagliaro 2011). Bendroth published a study 
using EtG determination in hair at time of autopsy as a chronic abuse 
marker but concerns with the established cut-off made interpretation 
difficult as levels below do not necessarily indicate alcohol abstention 
(Bendroth 2008) 
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Berger et al recently published a report on using EtG as an indicator of long 
term ethanol consumption in hair and fingernails. Hair and fingernail 
samples were obtained from student abstainers, increasing risk drinkers, 
and high risk drinkers. Hair samples showed the best sensitivity among the 
high risk drinkers while fingernail testing showed a high sensitivity among 
both the increasing risk and high risk drinkers. While this study shows an 
interesting application of EtG it will be critical to improve specificity and 
sensitivity in certain areas (Berger 2014).  
While EtG and EtS have both a high diagnostic specificity and sensitivity to 
ethanol, it is critical to note that there are false positives due to the ability 
to detect such low levels of the metabolites.  
 
ALCOHOL CORRELATED  ADDUCTS   
 
ACETALDEHYDE PROTEIN ADDUCTS  
 
Acetaldehyde protein adducts form when acetaldehyde generated during 
alcohol consumption react with proteins (hemoglobin, microsomal 
proteins) (Sillanaukee, 1992). While these protein adducts have been 
proposed as a marker for alcohol abuse, the lack of a validated method in 
serum has limited the investigation of these markers in the population. 
 
FATTY ACID ETHYL ESTERS (FAEES) 
 
Fatty acid ethyl esters (FAEEs) are formed by the esterification of free fatty 
acids with alcohol and are catalyzed by FAEE esterases. FAEEs are present 
in organs more prone to alcohol related damage such as the liver, pancreas, 
heart, and brain. It has long been known that FAEEs contribute to end 
organ damage after chronic consumption and interfere with normal 
working of mitochondrial membranes among other destructive effects 
(Laposata 1986).  
FAEEs are formed after ingestion of alcohol and parallel the increase of 
ethanol in blood, however due to the fact that they accumulate in other 
tissues there can be secondary elimination pathways slower than ethanol. 
As a result FAEEs can be detected for up to 24 hours in acute intoxications 
and up to 100 hours after last alcohol intake in chronic alcohol abusers. The 
detection window of FAEEs can be useful in differentiating a binge drinker 
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(acute intoxication) and chronic alcohol abusers. FAEEs also accumulate in 
hair by deposition through sebum allowing for detection up to 2 months, 
yet it is important to note that like EtG certain hair products can increase 
levels of FAEEs in abstaining persons.  
The Society of Hair Testing (SoFT) has established a set of cut-off values for 
the testing of FAEEs in hair samples using four esters (ethyl myristate, ethyl 
palmitate, ethyl oleate, and ethyl stearate). If the segment is 0-3 cm 
proximal to the scalp a value of 0.5 ng/mg is considered indicative of 
chronic excessive alcohol consumption; if 0-6 cm proximal to the scalp the 
cut-off value is 1.0 ng/mg (Kintz 2012). If the segment of hair is below 3 cm 
the results are to be interpreted with caution due to the issues of cosmetic 
treatments altering FAEEs. 
 
PHOSPHATIDYLETHANOL  
 
Phosphatidylethanol (PEth) is formed by transphosphytidylation of 
phosphatidylcholine in the presence of ethanol catalyzed by phospholipase 
D. Phosphatidylcholine is a protein found in cellular membranes and as 
such, PEth is incorporated into the membrane of red blood cells and can be 
detected after 2 weeks of alcohol consumption of around 50 grams or more 
per day. The half life of PEth in blood after abstention is approximately 4 
days and it has a diagnostic sensitivity of greater than 90% (Hartmann 
2006).  
In 2001 Hansson performed a study measuring PEth levels in 85 autopsies, 
70 of which tested positive (Hansson 2001). Detecting a direct metabolite 
of ethanol is extremely useful in the forensic context as it is a direct result 
of ante-mortem consumption; however, Aradottir observed in 2004 that 
postmortem formation of PEth occurred in the presence of ethanol. 
Samples need to be extracted within hours of autopsy and frozen at -80oC 
to limit the reaction. Due to the implication of sample preparation 
limitations the useable window of PEth in postmortem cases must be 
watched closely.  
 
SALSOLINOL  
 
Salsolinol is synthesized from the reaction of dopamine and acetaldehyde 
by the salsolinol synthase enzyme or by its reaction with pyruvate. After 
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consumption of alcohol salsolinol levels increase in blood and have been 
proposed as a contributor to the addiction process of alcohol (Mravec, 
2005). It is important to take not of the matrix tested as levels increase in 
blood, decrease in urine after acute alcohol consumption, and no 
significant difference in the brain of abusers and abstainers has been noted 
(Peterson, 2004).   
 
PRODUCTS OF ALCOHOL-INDUCED METABOLIC CHANGES 
 
5-HYDROXYTRYPTOPHOL (5-HTOL) 
 
5-hydroxytryptophol (5-HTOL) is a metabolite of the neurotransmitter 
serotonin (via monoamine oxidase enzyme MAO), a cellular communication 
chemical. Alcohol and acetylaldehyde disrupt the metabolism of serotonin 
so that an increase of 5-HTOL occurs in people consuming alcohol versus 
abstaining and can be measured up to 24 hours after consumption. In 2004 
Johnson et al used a ratio of 5-HTOL/5-HIAA (5-hydroxyindole-3-acetic acid) 
another metabolite of serotonin to determine ante-mortem ethanol 
consumption in post-mortem urine using LC-MS. The increase of serotonin 
metabolites in the urine indicated ethanol consumption prior to death (not 
attributed to post-mortem microbial formation) with levels above 15 
pmol/nmol classifying as positive (Johnson 2004). Including 5-HIAA in the 
measurment of 5-HTOL is critical to reduce the false positives that can 
occur from dietary sources of serotonin (Helander 1995). 
 
MEAN CORPUSCULAR VOLUME (MCV) 
 
Mean corpuscular volume (MCV) is the measurement of the average size of 
erythrocytes (red blood cells). After sustained drinking of 4-8 weeks, the 
size of red blood cells increase; likely as a result of toxic effects on bone 
marrow and development of red blood cells (increased number of vacuoles) 
and decreased membrane fluidity (Ballard 1997). Alcohol can also 
contribute to vitamin deficiencies as it interferes with B12 and folic acid 
absorption. Due to the 120 cycle of most erythrocytes, MCV values take 
longer to return to normal after cessation of drinking alcohol. 
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γ-GLUTAMYL TRANSFERASE (GGT) 
 
Gamma glutamyl Transferase (gGT) is a serum enzyme produced mainly in 
the liver and plays a significant role in the gamma-glutamyl cycle which is 
responsible for the synthesis and degradation of glutathione. It has been 
noticed that after exposure to increased alcohol intake (>60 g/day) for 
several weeks, the levels of gGT increase as a result of associated liver 
damage and release of gGT from the hepatocytes. After abstention, the 
levels return to normal range after 20-25 days (Rosman 1992). Whitfield 
noted in 2001 that there are several factors affecting gGT measurement 
such as hepatitis C, cirrhosis, carcinoma, cardiovascular disease, diabetes, 
obesity, and kidney failure. Whitfield also observed that there were some 
variations in levels of serum gGT among subject populations. Typically 
levels are higher in adult males than females, black subjects, smokers 
showed an average 24% increase, and women using oral contraceptives a 
10% mean increase of levels (Whitfield 2001). While gGT itself is not highly 
sensitive or specific for the indication of chronic alcohol abuse, it is 
commonly used alone or in conjunction with MCV and AST/ALT for a first 
assessment of abuse due to the wide availability of testing methods in 
clinical and laboratory settings. 
 
ASPARTATE AMINOTRANSFERASE (AST) & ALANINE AMINOTRANSFERASE 
(ALT) 
 
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are 
enzymes involved in amino acid metabolism. These cellular enzymes are 
found in body tissues such as liver, heart, brain, skeletal muscle, and red 
blood cells. Clinically these levels are measured often and used as an 
indication of liver health, with a ratio of AST to ALT exceeding 2.0 
suggesting liver damage. While AST and ALT are used as markers of chronic 
alcohol abuse, their increase results from an overall liver damage which can 
occur for a variety of reasons other than alcohol abuse, thus the diagnostic 
specificity and sensitivity are low. 
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CARBOHYDRATE DEFICIENT TRANSFERRIN (CDT): GENERAL ASPECTS 
 
Human transferrin (hTf) is an iron-binding protein that circulates in the 
blood transporting iron throughout the system. HTf is mainly synthesized in 
hepatocytes and contains a polypeptide chain, two iron metal binding sites 
one at the c terminus and on at the n terminus, and two N-linked 
carbohydrate side chains. HTf is comprised of 679 amino acid residues with 
a molecular weight of approximately 79 kD with two c-terminal lobe N-
glycosylation sites (asparginine-413 asparginine-611) responsible for 
binding two bi and/or triantennary carbohydrate side chains composed of 
N-acetylglucosamine, mannose, galactose, and sialic acid.  The terminal 
sialic residues are the only charged molecules and give the various isoforms 
of hTf their names.  
The largest isoform of circulating Tf is tetrasialo-Tf (75%) and contains two 
biatennary N-glycans with four sialic acid residues and a pI of 5.4. Minor 
glycoforms of hTf exist containing zero sialic residues (asialo-Tf, pI 5.9 ), one 
sialic acid residue (monosialo-Tf, pI 5.8), two sialic acid residues (disialo-Tf, 
pI 5.7 ), three sialic acid residues (trisialo-Tf, pI 5.6), and five sialic acid 
residues (pentasialo-Tf pI 5.2). Disialo-Tf, trisialo-Tf, and pentasialo-Tf are 
found in serum of normal subjects as well as traces of asialo-Tf, monosialo-
Tf, and hexasialo-Tf.  
 
Figure 1. Human Tetrasialo Transferrin Structure 
 
The metal ion binding sites fold into two structurally similar lobes, the N 
and C-lobes that contain conserved amino acids to aid in binding (two 
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tyrosines, one aspartic acid, and one histidine). Additionally two oxygen 
molecules given by a carbonate molecule stabilize the iron atom when 
bound to hTF. Iron binds to transferrin with high affinity at physiologically 
neutral pH (10-22 M) and has 3 possible forms, no iron bound 
(apotransferrin) and one or two iron molecules bound (holotransferrin), 
depending on the availability of Fe3+. Once iron is loaded, transferrin binds 
to its cell surface receptors and is endocytosed where the pH inside the 
vesicle is lowered to ~5.6 releasing the iron (Byrne 2010). In a healthy 
individual approximately 30% of transferrin is saturated with iron, during 
iron deficiency more apo-Tf is present in the serum. Alternatively iron 
overloading (hemochromatosis) increases the amount of transferrin with 
Fe3+ bound in serum (De Jong, 1990). 
 
The glycoforms of serum transferrin are characterized by their 
microheterogenicity, distinguished by isoelectric focusing (IEF) 
electrophoresis to discriminate based on their amino acid content, iron 
bound confirmations, and carbohydrate content of the branched chains. 
The N-glycan chains differ in their degree of branching carbohydrates, 
potentially binding 2, 3, or 4 structures terminating in a negatively charged 
sialic acid residues ranging from zero until 8. The approximate composition 
of each glycoform in normal serum is: asialo-Tf <1%, monosialo-Tf <1%, 
disialo-Tf 2%, trisialo-Tf 5%, tetrasialo-Tf 75%, pentasialo-Tf 15%, hexasialo-
Tf 2%, heptasialo-Tf <1%, and octasialo-Tf <1%.  
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Asialo-Tf < 1% Monosialo-Tf < 1% Disialo-Tf 2%
Trisialo-Tf 5%
Hexasialo-Tf 2%
Tetrasialo-Tf 75% Pentasialo-Tf 15%
Heptasialo-Tf < 1% Octasialo-Tf < 1%
 
Figure 2. Microheterogenicity of Human Transferrin in Serum 
 
Microheterogenicity of abnormal hTf glycoforms was reported by Stibler in 
1978 in the cerebrospinal fluid of alcoholics, half of which also showed an 
increase in the disialo-Tf in serum (pI 5.7). The glycoforms that increased 
concentration after sustained alcohol consumption of >60 g/day were 
disialo-Tf, monosialo-Tf, and asialo-Tf. These lower glycosylated isoforms 
are called carbohydrate deficient transferrin and comprise less than 1.8% of 
total serum transferrin in a normal subject. In 2001 Bergen attributed loss 
of one or more glycan chains to the accumulation of CDT by using ESI-MS of 
Tf Isoforms after IEF, however Flahaut showed using MALDI-MS that both 
N-glycan chains (major) and sialic acid moieties (minor) were being lost 
after chronic alcohol abuse in disialo-Tf fractions (Flahaut, 2003). 
Using current analytical techniques, IEF, capillary electrophoresis (CE), and 
high performance liquid chromatography (HPLC) asialo and monosialo-Tf 
fractions are not typically seen in healthy subjects. After chronic drinking of 
alcohol, the asialo-Tf can be noticeable along with a marked increase in 
disialo-Tf. Even knowing this, total transferrin is still calculated by adding 
the asialo, monosialo, and disialo-Tf values together.  
 
Genetic variations in the transferrin molecules can occur as a result of 
amino acid substitutions in the polypetptide chain potentially affecting the 
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final charge of the molecule. At least 38 variants have been isolated and 
characterized based on their electrophoretic mobility, however only 4 of 
these show a prevalence of 1%. Of these main variant groups (B,C, and D) 
the C1 subgroup is the most common and gives no interferences with 
current analytical methods as its main isoform is of pI 5.4 (tetrasialo-Tf). 
Heterozygotes of transferrin have two peaks for each glycoform and can co-
elute. This creates analytical problems especially with the BC and CD 
heterozygotes. The anodal B group can give a false negative result (lower 
pI) while the cathodal D group can give rise to false positives due to its 
amino acid substitution causing the pI to be >5.7 even though it possesses 
the same iron and carbohydrate content (tetrasialo-Tf) as the common Tf-C 
variants (Bean 1994). Plainly, subjects with Tf-BC variants will co-elute with 
non CDT isoforms of Tf-C variants even if heavy drinking is involved leading 
to false negatives and conversely subjects with Tf-CD variants will co-elute 
with CDT fractions of Tf-C variants even when no sustained alcohol 
consumption has occurred giving rise to false positives.  
 
While it is clear in the literature that sustained alcohol consumption of >60 
g/day for a period of at least 7-10 days will increase CDT, the biochemical 
mechanism for its increase is not well understood. Lakshman proposed that 
chronic exposure to alcohol affects cellular glycosylation, a critical and 
complex pathway in cells. Posttranslational modification of transferrin 
mainly occurs in the liver and requires several specific glycotransferases. 
Lakshman noted that the mRNA transcripts of sialytransferases in heavy 
drinkers were destabilized and reduced in number. As a result terminal 
sialic acid residues were not added to the branching carbohydrate chains as 
in normal subjects due to impairment of glycosylation leading to an 
increase of CDT (Lakshman, 1999). 
Stibler and Borg showed that an increase in acetaldehyde concentration 
reduced the activity of galactosyl- and N-acetylglucosiminyl transferases 
involved in the beginning stages of N-glycan synthesis of hTf in the Golgi 
apparatus of liver cells (Stibler 1991). The increase of acetaldehyde in the 
oxidative metabolism of ethanol by ALD would lead to the accumulation of 
CDT due to impairment of glycosylation. Sillanaukee proposed after 
reviewing several studies that there is likely not one single event 
responsible for the increase in CDT levels, but likely a combination of 
protein transport and changes in enzyme activity (2001). 
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Ramskogler tested whether hepatocellular damage could be a reason for an 
increase of CDT levels by performing apoptosis experiments on 72 
individuals suffering from alcohol toxic hepatic disorders. Along with CDT, 
gGT and liver enzymes (ASAT and ALAT) were measured as a marker for 
liver damage. While gGT and the liver enzyme levels increased and showed 
a strong correlation between them after acute hapotocyte damage, CDT did 
not suggesting that the increase of CDT is not directly linked with 
hepatocyte damage but hepatocyte metabolic impairment (Ramskogler 
2004). 
 
DIAGNOSTIC SENSITIVITY & SPECIFICITY OF CDT 
 
In any analysis it is critical to know the diagnostic sensitivity (ability for the 
marker to be correctly identified) and the specificity (ability for the marker 
to not be identified when absent) of analyte being tested with regard to the 
specific pathology of interest. In the case of chronic alcohol abuse, the ideal 
marker with a high sensitivity and specificity will be able to determine 
chronic alcohol abusers from moderate and non-drinkers as well as from 
persons suffering from other conditions that could give a false positive 
(liver cirrhosis, Tf-variants, pregnancy), be a direct metabolite or be directly 
affected by ethanol increase, and be dependent on the amount of alcohol 
consumed.  
While CDT is a good indicator of chronic alcohol abuse, there are other 
pathologies for which CDT levels can increase. Severe hepatic failure as a 
result of chronic viral hepatitis, primary biliary cirrhosis, and hepatocellular 
carcinoma can lead to false positive CDT results due to the overall low 
levels of transferrin present skewing the value of CDT. Also Congenital 
Disorder of Glycoyslation (CDG), hormone differences in woman (during 
pregnancy, menopause, or while on oral contraceptives), and alcohol intake 
in iron-depleted patients can lead to increased levels of CDT.  
A phenomenon called disialotransferrin-trisialotransferrin-bridging, 
prevalent in patients with cirrhosis of the liver, is an incomplete separation 
between the disialo-Tf and trisialo-Tf peaks. Di-tri-bridging is seen using 
HPLC and capillary electrophoresis methods at a frequency of ~0.8%. This 
strange occurrence was linked to an alteration in the glycosylation of the 
carbohydrate moiety, adding fucose which has been shown to increase 
retention times (Landberg, 2012). 
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Bianchi reported that gestational trimester and %CDT is independently 
associated to gestational week using the HPLC candidate reference method. 
An increase in %CDT in abstainers is marked (0.52%) from first trimester 
until the third trimester (Bianchi, 2011). Kenan et. al showed that an 
increase of disialo-Tf in the third trimester of pregnancy combined with a 
decrease in trisialo and tetrasialo-Tf could lead to false positives in 
pregnant women (Kenan, 2011). Bakhireva reported that 35 subjects 
joining a study at an average gestational point of 7.3 weeks showed a mean 
increase of 0.18% from 1.49% CDT by the end of their term. Using the 
approved cutoff value for their method of 1.7% (CDT/Total Tf x 100), this 
put 45.7% of the subjects positive for CDT (Bakhireva, 2012). Due to the 
nature of CDT increase in pregnant women it is important to be careful 
when reporting values.  
Bergström and Helander reported a statistically significant but small 
difference in hTf composition between genders using an HPLC method. 
Men showed slightly higher levels of tetrasialo-Tf as compared to women 
and slightly lower pentasialo-Tf than women however the amount of 
disialo-Tf to total transferrin did not differ significantly. They also noticed 
that those with a body mass index (BMI) above 30 showed a significantly 
higher mean value of disialo-Tf (Bergström, 2008).  
Traditional makers for chronic alcohol abuse mean corpuscular volume 
(MCV), γ-glutamyltransferase (gGT), and aspartate aminotransferase & 
alanine aminotranferase (AST/ALT) are prone to sensitivity and specificity 
issues. In general gGT has a sensitivity of 34-85%; however it has a low 
specificity since levels increase for non alcoholic liver disease, obesity, 
diabetes mellitus, and several other pathologies. MCV has a high specificity 
(80-90%) when determining chronic alcohol abuse as it takes 30 days of 
>60g ethanol consumption to slowly increase levels but suffers from low 
sensitivity because certain populations (e.g. vitamin B12 deficiencies) will 
be positive for increased MCV but not necessarily a direct result of chronic 
alcohol abuse.   
In comparison, CDT shows a high specificity for chronic alcohol abuse as it 
requires at least 7-10 days of >60g alcohol consumption before appearing 
in serum of healthy subjects and has a relatively long half life.  When 
evaluated against traditional markers, CDT measurement was surpassed 
only by the combination of CDT with gGT in cases of differentiating 
“moderate” from “heavy” drinkers (Sillanaukee 2001).  
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CDT: PRE-ANALYTICAL PROBLEMS 
 
Pathologies do play a role in CDT levels as well as differences in 
populations; however, it is important to note that pre-analytical handling 
can also lead to variations in CDT measurements. Several authors have 
written about the importance of storage temperature and time, freeze-
thaw cycles, type of collection tubes (anticoagulant or not), and time from 
sample collection and centrifugation. In general most authors agree that 
CDT is stable at -20oC for months after centrifugation of whole blood and 
serum is removed and days to a weeks at 4oC; also freeze thawing does not 
appear to effect the samples greatly unless done multiple times. Stibler 
reported in 1986 that heparin impaired in vitro Fe3+ saturation and a 25% 
increase of CDT was found after 3 days at room temperature storage. Arndt 
reported in 2001 that samples centrifuged 1 hour, 24 hours, 48 hours, and 
144 hours after collection showed a marked increase in CDT values (Arndt, 
2001). This could have been due to bacterial activity of neuraminidase 
cleaving parts of the glycan chains.  
 
CDT: ANALYTICAL METHODS 
 
There are several analytical methods available to determine CDT in serum, 
the most frequent being immunoassay, capillary electrophoresis (CE), and 
high performance liquid chromatography (HPLC). In routine laboratory 
work it has been determined that immunoassay should be used only as a 
screening method later confirmed by CE and/or HPLC methods. While CE 
and HPLC have been show to have good correlation, the Working Group on 
Standardization of Carbohydrate-deficient Transferrin of the International 
Federation of Clinical Chemistry and Laboratory medicine (WG-CDT-IFCC) 
declared HPLC the candidate method based on its superior selectivity of 
detection (460nm λ-specific for Fe3+ bound Tf) vs. CE’s 200-214nm λ at 
which all proteins absorb (ultraviolet UV). 
 
IMMUNOMETRIC METHODS 
 
Utilizing immunoassays to measure CDT is a common method, especially in 
clinical settings, due to their ease of use and suitability for routine analyses. 
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Stibler et al first analyzed CDT by performing isoelectric focusing (IEF) 
separating the isoforms based on their pIs, followed by 
immunoelectrophoresis, and finally western blot for visualization of 
proteins. A separation step via anion exchange micro column was required 
before IEF to isolate CDT (pI >5.7) from serum. Alden et al demonstrated 
that affinity chromatography (micro-column separation) of samples from 
the Axis-Shield %CDT immunoassay left a marked amount of trisialo-Tf in 
samples potentially creating false positive CDT values (Alden 2005).  
In an effort to remedy the problem of poor separation, complex 
electrophoretic stages, and enhance robustness several kits were designed 
that are exploit ion-exchange microcolumns to remove non CDT isoforms 
followed by various immunochemical detection methods (enzyme, 
radioimmunoassay, turbidimetric). While increasing productivity, a main 
concern of most CDT immunoassays still remained; that the antibodies 
used recognized all transferrin glycoforms, not specifically CDT epitopes 
and were reliant on a good separation of CDT from total transferrin prior to 
detection. Helander reported on the fact that genetic variants were not 
distinguishable in immunoassay testing because CDT isoforms are not 
resolved and visualized as they are in CE or HPLC (Helander 2001). In 
addition, the selectivity of separation cartridge  technology in kits in 
conjunction with various detection methods increases variability making it 
difficult to fully compare and standardize results, something crucial in 
forensic medicine when the legal system is involved. 
This was improved by the creation of the N Latex CDT direct immuno-
nephelometric assay developed by Siemens Healthcare Diagnostics 
(Marburg, Germany) which uses monoclonal antibodies and CDT-like 
antigens that will agglutinate if no CDT is present in the sample being 
tested (otherwise it will not) and can easily be read with a 
spectrophotometer. Further increasing its appeal there is no sample 
pretreatment and associated spectrophotometers can be used with bar-
coded sample tubes automating the testing process.  
 
CHROMATOGRAPHIC METHODS 
 
Taking advantage of the fact that transferrin isoforms differ in charge based 
on their terminal sialic acid residues, chromatographic methods were 
developed to increase specificity. Separation of the less abundant CDT 
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isoforms from the higher total serum transferrin was critical to achieve 
higher specificity and selectivity as well as to determine Tf genetic variants. 
Jeppsson et al created a method based first on anion exchange separation 
using columns followed by salt gradient elution and direct detection of CDT 
at a wavelength of 460 nm (Tf-Fe3+ complex) (Jeppsson 1993). This method 
was improved on by Helander et al by modifying the salt gradient elution, 
changing the anion exchange column, and detecting CDT at 470 nm 
(Helander 2003). The high specificity of HPLC warranted it to be chosen as 
the candidate reference method for CDT testing by the Working Group on 
Standardization of Carbohydrate-deficient Transferrin of the International 
Federation of Clinical Chemistry and Laboratory medicine (WG-CDT-IFCC) as 
previously stated. 
 
ELECTROPHORETIC METHODS 
 
At the discovery of carbohydrate-deficient transferrin, the method of 
separation was isoelectric focusing which precisely separated Tf isoforms 
based on their pI values. While very specific and still considered a gold 
standard separation method today, there were inherent issues in the 
detection and quantitation steps following IEF not to mention the time of 
analysis involved. Western blot analysis and/or staining of gels with silver 
(or other) stains were only as sensitive as the reagent and detection 
method. Also, the quantitative aspect of these off line detection techniques 
is not as precise or reproducible as liquid chromatography or capillary 
electrophoresis techniques, and therefore not commonly used in routine 
analysis.  
Many methods involving capillary electrophoresis are being used to 
determine CDT values, especially capillary zone electrophoresis (CZE), 
separating the various isoforms based on their electrophoretic mobilities 
(charge/mass). In 1998 Tagliaro et al proposed a method for the separation 
and detection of CDT by CZE using an uncoated capillary and 100 mM 
sodium tetraborate buffer at pH 8.3. Samples were incubated with FeCl2 
and sodium bicarbonate to saturate the Tf iron binding sites (to decrease 
variations in mass between molecules) basing the separation on overall 
charge contributed by the terminal sialic acid residues. A direct on line 
detection of Tf was done using a UV detector at 200 nm wavelength 
(Tagliaro 1998). In 2000 a further improvement to this method was done 
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adding diaminobutane (DAB) to the buffer, reducing protein interaction 
with the capillary walls (silanol groups) increasing analytical sensitivity and 
selectivity (Crivellente 2000).  
Several commercial kits have become available for the testing of CDT using 
capillary electrophoresis attempting to simplify sample prep and analysis 
time in order to increase routine use. One such kit, CEoFix CDT (Analis 
Namur, Belgium) released in 2001, employed a dynamic double coating of 
the fused silica capillary (i.d. 50 um, 60.2 cm), buffer system (pH 8.4) 
provided by the manufacturer containing ferric iron removing the pre-
analytical step required for saturation, and took approximately 8 minutes of 
analysis time. Tagliaro et al later critiqued that even though the 
reproducibility of the kit was high, there was not a good separation 
between disialo-Tf and trisialo-Tf especially when trisialo-Tf was in higher 
concentrations suggesting that the decrease in resolution was not worth 
the advantage of direct measurement of serum (Tagliaro 2002). Shortly 
after Legros published a slightly modified version of the manufacturer’s 
protocol including an iron saturation step prior to sample analysis allowing 
for good separation of transferrin isoforms (Legros 2003).  
Many experiments testing various dynamic coatings (diaminobutane, 
spermine, CEofix® double coating, diethylenetriamine) and buffers have 
been published in the literature attempting to improve analytical sensitivity 
and reproducibility whilst maintaining relatively short analysis time. In fact 
after Lanz pointed out areas where the Analis CEofix® kit could be 
enhanced, an improved version was released in 2003 that obtains better 
separation between disialo and trisialo-Tf. A huge advance in the routine 
analysis of CDT came in the form of the Capillarys multicapillary 
electropherograph created by Sebia (Evry, France). A fully automated 
analysis and quantification can be performed including an iron 
pretreatment and direct UV detection at 200 nm simultaneously in seven 
channels.  
 
MASS-SPECTROMETRIC METHODS 
 
While mass-spectrometric analysis of CDT Mass-spectrometric analysis of 
human transferrin has been used to determine the molecular structure of 
the released carbohydrate chains, particularly in the case of disorders 
associated with abnormal Tf (carbohydrate deficient glycoprotein 
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syndrome, CDGS), it has never really been adopted due to its complexity 
and difficulties with quantitation. In 2003 Kleinert et al isolated transferrin 
using ion-exchange HPLC with UV detection followed by concentration of 
the transferrin fraction and detection via liquid chromatography-
electrospray mass spectrometry. They were able to measure up to ten 
isoforms and apply the method to samples determining persons with 
congenital disorders of glycosylation (CDG-Ia, Ib, Ic, Ie, If, and IIa) as well as 
other pathologies (Kleinert 2003).  
In 2005 Alden et al used matrix assisted laser desorption ionization time-of 
flight (MALDI-TOF) to determine the composition of eluate from the Axis 
Shield immunoassay (Axis Shield, Oslo Norway). According to the 
manufacturer the assay only measures a-, mono-, and disialo-Tf after 
separation via ion-exchange cartridges and turbidimetric detection (%CDT 
determined), however Alden measured trisialo-Tf in the eluate, potentially 
contributing to false positives (Alden, 2005). 
Castillo Busto published an article using HPLC with online coupling of an 
inductively coupled plasma mass spectrometer (ICPMS) that allowed for the 
screening of transferrin molecules by atomic presence of iron only allowing 
them to be further characterized (lower detection limit of 0.03 µMTf) via 
MALDI-TOF and electrospray mass spectrometry (ESI-Q-TOF). MALDI-TOF 
proved to be sensitive to analyte concentration but ESI-Q-TOF gave a 
unique profile of CDT to apply towards diagnosis of alcoholism (Castillo 
Busto 2005). As previously mentioned, Landberg et al utilized MALDI-TOF to 
determine the composition of CDT samples containing di-trisialo-Tf bridging 
in 2012 and discovered a fucosylation of the carbohydrate branches 
(Landberg 2012). 
 
FORENSIC APPLICATIONS OF CDT TESTING 
 
A major concern of legal medicine is the chronic abuse of alcohol involving 
both living and dead persons. Testing a person for chronic alcohol abuse is 
important in cases involving license re-issuing, child custody hearings, 
workplace fitness (as in testing a pilot), and workplace safety (operating 
heavy machinery) among several others. Bortolotti et al. tested the 
reliability of CDT as a marker for risk of driving under the influence in 2007. 
Their study showed that in the control group 96.1% of subjects were 
negative for CDT levels above the cutoff while only 40% were negative in 
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the group of subjects stopped for drunken driving (Bortolotti 2007). This 
study, as well as others that are similar, support the measurement of 
increased CDT levels as a risk of drunk driving even though not objective in 
their findings. In 2014 Maenhout et al performed a study called Recidivism 
of Alcohol Impaired Driving or ROAD following 517 randomly selected 
drivers in Belgium who previously had their licenses confiscated. The study 
followed the drivers for 3 years and not only % CDT values were measured 
but also gGT, AST/ALT, and MCV. After performing logarithmic regression 
on their samples and using 1.6% CDT as their upper limit of normal (ULN), 
they determined that CDT was useful to assist in the prediction of 
recidivism for drunken driving. When gGT and ALT values were also 
determined after admittance into license re-granting programs, they were 
found useful for predicting recidivism but not to the extent of CDT 
(Maenhout 2014). 
CDT determination is also useful to test persons involved in a job that 
requires strict safety measures such as a pilot or public transportation 
driver. Fustinoni et al showed a high specificity and sensitivity of CDT for 
predicting alcohol abuse among drivers but stated that a high CDT level is 
not a definite indicator of abuse (Fustinoni 2009). However it is clear that 
being aware of an employee’s habits is useful when deciding if they can 
continue a job where others’ and their own safety are at risk. 
 
POST-MORTEM APPLICATIONS OF CDT TESTING 
 
Death is directly or indirectly a result of alcohol abuse in many forensic 
cases especially homicides, suicides, and accidental deaths (including traffic 
accidents) and can give information to investigators. Half of all alcoholics 
are estimated to have a negative BAC at time of death (Sadler 1996). While 
a useful tool to determine ante-mortem habits, testing for alcohol abuse 
can prove difficult due to the short time frame of ethanol in the system, 
inadequate background information, and often lack of anatomo-
pathological findings during autopsy. Commonly associated pathological 
findings in the liver (fatty liver, cirrhosis), pancreas (atrophy), brain 
(atrophy), and heart (hypertrophy, fibrosis) are not only indicative of 
alcohol abuse but have many underlying pathologies that could contribute.  
Major issues in the testing of post-mortem samples, especially blood, is 
that they are susceptible to bacterial action due to decomposition, 
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autolysis, and redistribution of analytes due to free diffusion across 
membranes after loss of membrane potential. It is critical to know when 
given an analyte concentration whether it could be a result of post-mortem 
distribution. Under-estimated values can occur when the analyte in 
question has been diluted after release from where it was concentrated 
(for example in an organ) or overestimated because it has migrated and 
concentrated to an area of collection falsely increasing the result. The act of 
decomposition itself creates alcohols and can interfere with testing for 
ethanol post-mortem. Ethanol can also be produced by bacteria in a stored 
sample after collection especially when not stored or preserved properly 
(Gill, 2005).  
In the case of post-mortem blood samples they are not like traditional 
whole blood in that the cells within have begun to rupture (autolyse) and 
release their contents. Of interest, the red blood cells which make up 
approximately 45% of whole blood burst releasing hemoglobin (an iron 
carrying oxygen transport protein). This causes the normal separation of 
serum from coagulation factors and cellular components to be impaired; 
not obtaining a clear separation as would be done ante-mortem which 
could pose problems for the forensic analyst. 
To address some of the questions plaguing post-mortem blood samples 
with respect to CDT testing Simonnet et al tested several variables including 
effect of hemolysis, site collection, and sample storage. Addition of 
hemoglobin to samples was not shown to effect the CDT results however 
hemolysis of the samples showed a decrease of CDT vs. the non-hemolysed 
sera likely due to the dilution of red blood cells’ contents which does not 
contain transferrin. As for site of collection, no significant difference was 
found between cardiac or femoral blood CDT levels. Storage of CDT for two 
weeks at +4oC or -20oC was shown to have no significant effect on the CDT 
values, however repeated freezing and thawing cycles showed a decrease 
in the value of CDT and should be avoided if possible (Simonnet 1999).  
In order to further investigate the stability and post-mortem distribution of 
CDT, Rainio et al performed a study on 280 serum samples from 70 
cadavers testing different retrieval sites (femoral blood prior to autopsy, 
right femoral blood at autopsy, left femoral blood at autopsy, and vena 
cava) and compared capillary zone electrophoresis (CZE) and HPLC 
methods. Their findings showed that CDT was stable up to several days of 
cold storage and the results were not significantly different amongst 
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collection sites, reconfirming that post-redistribution was not a factor on 
the analysis. Previously CDT was shown to remain stable up to 96 hours in 
post-mortem samples and Rainio corroborated this data with an average 
post-mortem interval (PMI) of 95 hours (range 39.2-152.4) (Rainio 2008). 
CDT has also been measured in vitreous humor by Berkowicz et al and 
found to be a good marker for chronic alcohol abuse. The fact that the 
vitreous humor resides in its own compartment segregated from bacterial 
action is helpful, however the shorter window for collection of sample 
limits it use (Berkowicz 2000). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
EXPERIMENTAL PROCEDURES  
 
INTRODUCTION AND AIM 
 
Determining carbohydrate deficient transferrin at time of death can aid 
investigations, allowing for a more detailed view of ante-mortem 
behaviors. At this time, little testing has been done on post-mortem blood 
determination of CDT. Capillary zone electrophoresis offers a relatively 
quick and robust method with which to garner this information.  
A study of post-mortem samples obtained from the medical examiner and 
separated by CZE was performed to determine the usefulness of CDT as a 
post-mortem indicator of ante-mortem chronic alcohol abuse.   
 
MATERIALS & METHODS 
 
CHEMICALS 
 
All reagents used for buffer preparation were from Sigma Aldrich (St Louis, 
USA). A stock solution of 564 mM boric acid brought to pH 8.15 by 6 M 
NaOH was prepared weekly and kept at room temperature for use. A 90 
mM solution of 1-4-diaminobutane (DAB) was prepared in 0.05 M HCl and 
stored at room temperature. In order to obtain iron saturation serum was 
pretreated with a ferric iron solution contained in the CEofix™ CDT kit 
(Analis, Namur Belgium).  
For acid treatment of samples, stock solutions of 0.2 M HCl and 0.1 M 
sodium tetraborate were made and kept at room temperature. Samples 
were centrifuged in Amicon Ultra centrifugal filter units with a 0.5 mL 
capacity and 50 K molecular weight cutoff (Millipore, ) using a 
microcentrifuge. 
 
SAMPLE SELECTION AND PREPARATION 
 
Samples were obtained with no restrictions from the Office of the Chief 
Medical Examiner (Farmington, CT). Samples were taken at time of autopsy 
and put in glass blood collection tubes (red top) and serum separator gel 
tubes (yellow top) made by BD vacutainer (Plymouth UK) and stored at 4oC 
until pickup. Once samples were retrieved they were brought to the 
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University of New Haven (West Haven, CT) and were centrifuged for 10 
minutes at 12000 x g. After centrifugation the “serum” fraction was 
pipetted off and put into 1.5 mL microcentrifuge tubes and stored at -20oC 
until analysis. 10 µL of serum was pretreated with ferric iron at a dilution 
(1:8 for traditional method, 1:3 for acidic treatment method) and incubated 
at 4oC for 10 minutes, after which it was centrifuged again to further clarify 
the sample. Samples were transferred to vials appropriate to analysis on 
the CE instrumentation. 
Some testing of acid treatment of serum samples to remove interferences 
in the beta region of electropherograms where transferrin migrates was 
done. The main issue in this area is the interference of hemoglobin as it has 
a similar migration pattern to that of transferrin and is found in great 
abundance in hemolyzed post-mortem blood. In a paper published by 
Griffith they characterized the structure of hemoglobin proteins using ESI-
MS. In the article they treated their samples with HCl to disrupt the 
heterodimers and dimers so that they could analyze the fractions (Griffith 
2003). Adopting this, acid treatment of samples was done to breakdown 
the larger tetramers in an effort to alter their mobilities to a different 
region of the electropherogram. As such 0.2 M HCl was added to 300 µLs of 
serum until a pH of 3.5-4.0 was reached. After incubation overnight at 4oC, 
samples were applied to 50 k molecular weight cutoff filter units and spun 
at highest speed in a microcentrifuge for 15 minutes. Post centrifugation 
samples were brought back to a physiological pH (7.5-8.5) using 0.1 M 
sodium tetraborate and incubated overnight at 4oC. Bringing the pH back to 
physiological levels was done to regain transferrin conformation. 
 
ELECTROPHORETIC CONDITION 
 
Separation was achieved using a Beckman Coulter P/ACE-MDQ capillary 
electropherograph (Beckman Coulter, Fullerton CA) operating a UV-Visible 
detector at wavelength of 200 nm. Instrumentation control, data 
acquisition, and analysis were all done using 32 Karat software provided by 
the manufacturer (Beckman Coulter). Polyamide coated fused silica 
capillaries were obtained from Composite Metal Services Ltd. (West 
Yorkshire, UK). 
The conditions for separation are as follows. A 60 cm polyamide coated 
fused silica capillary with an internal bore of 30 µm and effective length of 
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50 cm; running buffer composed of 154 mM boric acid containing 6 mM 
DAB at pH 8.15; capillary temperature of 25oC; detection by UV-Visible at 
200 nm; injection with positive pressure at 0.5 psi for 30 sec; voltage +30 
kV; normal polarity. 
At the start of each day the capillary was conditioned as follows to increase 
reproducibility and capillary regeneration: 20 min 1 M NaOH, 20 min H2O, 
20 min 564 mM boric acid pH 8.15, 20 min running buffer pH 8.15. Before 
each sample run a shorter rinse program was used with the same 
components at reduced times (3 min) to maintain reproducibility. 
Valley to valley integration of peaks measuring the transferrin glycoforms 
present ranging from asialo-pentasialo-Tf was performed to obtain %CDT. 
%CDT was calculated by measuring and adding the areas under the curve of 
asialo-, monosialo-, and disialo-Tf and dividing it by the total area of the Tf 
glycoforms (a-,mono-,di-, tri-, tetra-, penta-), finally multiplying by 100 to 
get percentage. A cutoff value based on literature using serum and %CDT, 
to discern between normal or elevated was determined to be 1.8% 
(Delanghe 2009). All statistical analyses were performed in Excel with TTEST 
parameters being unpaired, one-tailed, unequal variance p values <0.05 
considered statistically significant. 
 
RESULTS AND DISCUSSION 
 
GENERAL DATA COLLECTION 
 
Separation by capillary zone electrophoresis to determine %CDT was done 
on post-mortem blood samples obtained at autopsy from the Office of the 
Chief Medical Examiner (OCME). 498 autopsies yielded a total of 996 
samples (one red top tube, one yellow top) were tested, 89 obtained 
interpretable electropherograms, 12 of which were discarded since they 
could not be reproduced, 5 discarded due to their lack of autopsy 
information. 72 samples (14.5%) were further investigated to determine 
the significance of CDT testing as a forensic tool. No significant differences 
between the types of collection tubes were found when compared 71 
times; the average difference between the two tubes was 0.06% ± 0.34%. 
The average %CDT found in the 72 samples that were interpretable and 
could be repeated was found to be 2.39% ± 2.49% with a range of 0.43-
13.04%. 16 samples were below 1% CDT and 27 samples measured above 
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the cutoff value of 1.8%, 13 of the 27 were above a level of 4%. In 24 
samples a positive blood alcohol content (BAC), an indication of acute 
ethanol consumption (above 0.08% considered illegal for driving) at time of 
death was found with an average of 0.17% ± 0.11%, 18 of these subjects 
also had a %CDT above normal range. In 6 cases %CDT was not above the 
cutoff value, 4 of the 6 at 1.00% or below. No BAC testing was done in 5 
cases, typical of the natural manner in which they died. 
General demographic data of the samples showed a population composed 
of 16 females and 56 males with an average age of 41.57 years ± 17.5. No 
significance of gender on increased %CDT was found (p value 0.18). The 
racial profile of the population consisted of 54 Caucasians, 14 Black, and 4 
Hispanic/White subjects and showed no statistical significance between 
Black persons or Caucasians for prevalence of increased %CDT (p value 
0.18). BMI was calculated for subjects based on their height and weight and 
placed into categories based on the National Institute of Health (NIH) 
guidelines; below 18.5 underweight, 18.5-24.9 normal, 25-29.9 overweight, 
>30 obese. The average BMI was 26.99 ± 5.55 with a distribution of: 1 
underweight, 26 normal weight, 26 overweight, and 19 obese subjects with 
increase of BMI in relation to an increase in %CDT not having statistical 
significance (p value 0.12).   
Anatomo-pathological findings as reported by the medical examiners were 
reviewed when supplied. 30 cases showing signs of pathologies associated 
with chronic alcohol abuse (cirrhosis, fatty liver, cardiovascular disease, 
cardio hypertrophy) were found, 16 of them also had a %CDT above normal 
value showing a strong correlation between increased CDT levels with 
pathological findings indicative of chronic alcohol abuse (p value 0.01). 
Manner of death was distributed as 37 accidental, 7 homicides, 20 natural, 
and 8 suicides. 
Manner Total # 
%CDT 
AVE 
%CDT 
STDEV 
# 
Positive 
%BAC 
AVE 
%BAC 
STDEV 
# 
Positive 
Accident 37 (51%) 2.6 2.7 16 0.10 0.12 19 
Homicide 7 (10%) 1.4 0.6 1 0.01 0.04 1 
Natural 20 (28%) 2.9 2.8 9 0.01 0.04 3 
Suicide 8 (11%) 1.2 0.5 1 0.01 0.04 1 
Table 1. Distribution of Data Based on Manner of Death Including %CDT and 
BAC Values 
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A prevalence of increased %CDT values was seen in the accidental and 
natural cases whilst the smallest portion in homicide and suicide cases. It is 
difficult to draw conclusions based on these results because percentages of 
cases being homicide and suicide are low with respect to accident and 
natural making statements of linked %CDT increase unwise. It is interesting 
to note however that in 19 of the cases where an acute intoxication was 
reported, the manner of death is accidental with 13 having a corresponding 
increase in %CDT above the normal range. There is a high correlation of 
increased %CDT values and increased BAC values in the accidental death 
population (p value 1.2e-6). Accidental deaths resulted from 
overdose/intoxication in 17 cases, asphyxiation in 1 case, and multiple 
blunt traumatic injuries in 19 cases. Of those who suffered blunt force 
traumatic injuries, 10 were involved in motor vehicle accidents, 3 of those 
having a %CDT above the cut-off value.   
 Post-mortem interval (PMI) from the time pronounced dead until 
centrifugation are as follow: 
 
 
PMI 
AVE 
(hrs) 
PMI 
STDEV 
# 
%CDT 
AVE 
%CDT 
STDEV 
# Positive 
Within 
PMI 
% 
Positive 
Total 
0-48 33.5 12.4 22 2.8 2.8 10 (45%) 37% 
48.1-96 63.6 10.9 20 2.4 2.5 7 (58%) 26% 
96.1-144 123.2 12.0 16 1.9 1.5 6 (37%) 22% 
144.1-192 176.3 9.8 6 3.5 4.4 3 (50%) 11% 
192.1> 267.3 55.9 5 1.8 1.8 1 (20%) 4% 
Table 1. Post-Mortem Interval of Interpretable Samples with %CDT Values 
for Associated Time Ranges 
 
As is shown by this table, a significant increase of %CDT values as PMI 
increases is not apparent as the CDT positive values are represented in 
fairly equal amounts, in fact most obtained at 144 hrs or below perhaps 
indicating some samples can still be measured beyond previously tested 
limits. Higher PMIs were a combinative effect of longer autopsy intervals 
and longer times held at 4oC for pickup at the OCME. It would be wiser to 
have an in-house area to at least centrifuge the sample for immediate 
storage.  While little difference amongst PMIs is a positive finding, the small 
sample size can by no means conclude that PMI has less of an effect on 
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%CDT than thought. It is interesting to note that interpretable data 
decreases as PMI increases as seen by total number of samples dramatically 
lowering after 144 hrs. The issue may not only be the affect of post-mortem 
interval on %CDT so much as the inability for the CZE method to separate 
and detect the CDT. As previously stated post-mortem serum samples 
suffer from hemolysis and can interfere with the detection of CDT. There 
are many proteins in whole blood that may not partition according to 
normal centrifugation due to the poor state of post-mortem blood, 
therefore these can also interfere with detection as a UV-visible detector 
measures proteins indiscriminately.  
 
CASE EXAMPLES 
 
Daily control runs consisting of a pooled transferrin sample with increased 
levels of CDT were run as a way to measure reproducibility since an internal 
standard could not be used. Intraday testing of a serum sample control (5 
times) showed RSD values below 10% with interday testing of serum 
sample control RSD value below 20% for CDT% and absolute migrations 
times below 1% intra-day.   
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Figure 5. Electropherogram of Pooled Serum Control 
 
Figure 5 shows an electropherogram of the daily control, transferrin 
glycoforms are represented as numbers 0=asialo-Tf all the way to 6= 
hexasialo-Tf. The control shows the resolution of asialo-Tf through trisialo-
Tf with some peak overlap between tetrasialo and pentasialo-Tf. For this 
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reason tetrasialo and pentasialo are measured as one valley-to-valley 
integration event when calculating %CDT for this method. 
 
CDT 1.53% 
BAC 0.00%
PMI 9.96 hrs 
AGE 42 yr
BMI 27.5
2 3
4
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Figure 6. Electropherogram of Subject with Negative %CDT and BAC 
 
Figure 6 shows an electropherogram of a CDT and BAC negative subject 
who died by suicide. There is a clear resolution of peaks with absolute 
migration time differences measured against the day’s control to be under 
1%. While this subject did not die with alcohol in their system it is not 
known whether they were an abuser of alcohol and it contributed to their 
demise. As can be the case in suicides by hanging, internal exams are not 
always performed (time constraints, clear cause and manner of death, 
family wishes) making the judgment of pathological findings consistent with 
chronic alcoholism impossible. The use of %CDT in this case can be critical 
in that it allows for the measurement of a chronic alcohol abuse marker 
while maintaining efficiency of the OCME. 
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CDT 0.60% 
BAC 0.26%
PMI 68.25 hrs 
AGE 55 yr
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Figure 7. Electropherogram Negative for %CDT with Liver Cirrhosis 
 
Figure 7 depicts the electropherogram from an individual who died of 
multiple drug toxicity and showed a negative %CDT, positive BAC. The 
subject suffered from cirrhosis of the liver, hypertensive cardiovascular 
disease, and cardiomegaly all consistent with the chronic consumption of 
alcohol. The interesting point is that the %CDT was low, 0.6%. While there 
is a peak near to the disialo-Tf glycoform integration was performed, 
careful not to include neighboring peaks. The relative migration times 
where in accordance to the daily control (<1%) lending confidence to the 
selected peaks. The results of this data could suggest that the person, while 
recently ingesting alcohol, could be abstaining by large, perhaps due to the 
state of their liver. While some discrepancy may be a result of poor peak 
resolution it is clear that the trisialo-Tf peak is higher with respect to the 
disialo-Tf and both peaks are not very large. The low %CDT would be 
consistent with these observations. 
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CDT 4.35% 
BAC 0.00%
PMI 50.50 hrs 
AGE 43 yr
BMI 29.8
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Figure 8. Electropherogram of Chronic Alcohol Abuser with Pathological 
Findings 
 
Figure 8 shows an electropherogram of a subject with elevated %CDT 
indicative of chronic alcohol abuse ante-mortem. The subject had a history 
of abuse along with fatty liver at time of autopsy. While it was not a 
mystery that the person was an alcoholic the %CDT information supports 
this fact and tells the medical examiner that the subject was likely still 
consuming high quantities (>60g/day) up until their death. 
 
 
CDT 4.03% 
BAC 0.19%
PMI 127.83 hrs 
AGE 23 yr
BMI 21.7
2 3
4
5
0
 
Figure 9. Electropherogram of Increased %CDT without Pathological 
Findings 
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Figure 9 shows an electropherogram of a subject with elevated levels of 
CDT and BAC but no pathological findings at time of autopsy. While an 
acute intoxication measured by BAC levels is clear, it might be of interest to 
know if the subject was an alcohol abuser to determine a behavioral 
pattern that might be helpful to investigators. The subject in the above 
electropherogram suffered from severe ethanol, cocaine, and heroin 
toxicity. %CDT allows us to infer that this was most likely not a one-of or 
two-of event that ended poorly but a pattern of abuse at least in reference 
to alcohol. Moreover the lack of pathological findings could be a result of 
his young age, not allowing enough time for the pathology to present and 
would go undiagnosed. This might be of importance, for example, if the 
individual was involved in other crimes or spent time around those who 
were. 
 
 
CDT 2.54% 
BAC 0.10%
PMI 75.5hrs 
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Figure 10. Electropherogram of Subject Involved In a Homicide Showing 
Increased BAC and CDT Levels 
Another interesting case is depicted in figure 10. The subject received a 
stab wound of the chest and had a positive BAC at time of death as well as 
an elevated level of %CDT. These facts taken together can indicate a 
chronic abuse of alcohol and engagement in risky behaviors. 
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INTERPRETATION ISSUES 
 
All samples were measured against their respective daily controls and any 
that did not maintain relative migration time ratios of <1% were not 
included. A large frustration was the myriad of interfering proteins 
contained in these post-mortem samples. A preliminary effort was made to 
find a way to precipitate out these interferences with the aim of reducing 
their hindrance on interpreting CDT. In brief, calcium chloride, ammonium 
sulfate, and ammonium persulfate were used in varying concentrations and 
volumes to see if incubation would clean up the sample before analysis. 
The pretreatment steps were often too severe (removing all proteins) and 
at lower levels had no real effect worth the potential of protein loss, not to 
mention the intense current spikes that would break capillaries even after 
sample dilution before injection. The reality of the method was that all 
proteins were precipitated in an indiscriminate and irreproducible fashion, 
separation was affected by current spikes even at low concentrations of 
salts, and quantitative analysis of %CDT would likely have been affected by 
this.  Moving beyond salt precipitation, a major interfering protein was 
addressed. Hemoglobin, found in large concentrations in hemolyzed 
samples migrates at a similar time as the transferrin glycoforms often 
masking their pattern due to hemoglobin’s high peaks. Hemoglobin 
proteins in the serum fraction of ante-mortem blood are normally 
contained in the red blood cells and centrifuged prior to testing, however in 
post-mortem samples the red blood cells are often lysed, releasing their 
contents. Acid treatment of hemoglobin as described in the methods 
section was applied to post-mortem samples prior to CDT testing to verify 
the effectiveness of altering the migration time of hemoglobin by resolving 
the tetramers into smaller species with different mobilities. 
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Figure 11. Electropherogram of Transferrin Glycoforms in Healthy Individual 
 
Figure 11 depicts a normal serum distribution of CDT in a healthy subject, 
indicating the gamma (γ) and beta () regions. The gamma region of the 
electropherogram shows the migration of the gamma globulins found in 
blood. While this is a large mass of unresolved proteins it is clear that they 
do not interfere with the detection or measuring of CDT isoforms in the 
beta region. This electropherogram is generally free of other interfering 
proteins but in the case of post-mortem samples there are a lot that 
migrate at the same time as transferrin, one in particular hemoglobin 
(Figure 12).  
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Figure 12. Electropherogram of Hemoglobin Interference in  Region 
 
The analysis of acid treated samples was done in the same way as all other 
samples, the difference being the sample pretreatment discussed in the 
methods section and adopted from another method used previously from 
the lab.  
 
Acid Treated
No Treatment
Figure 13. Electropherogram of a Sample with and Without Acid Treatment 
 
 
Preliminary results were obtained for a normal control and one other 
sample (Figure 13) maintaining relative migration ratios <1% with daily 
controls. The sample in figure 13 was chosen because the pattern of 
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transferrin was clear, with only some low quantities of other proteins. This 
preliminary separation was done for two reasons, the first to make sure 
that while the normal serum (provided by live subject) was not affected by 
acid treatment neither would a post-mortem sample, and second to see if 
the acid treatment while developed for hemoglobin removal would be able 
to address any of the other proteins in the  region. The resulting 
electropherograms show no marked improvement in the transferrin 
pattern, however it at least showed no significant change in the level of 
%CDT measured with and without treatment implying little affect on the Tf 
molecules. 
The lack of data obtained was in great part due to the poor separation 
achieved for more “ugly” samples and small number of experiments 
performed. In most cases a discernable transferrin pattern was not found. 
Conclusions based on the improvement of acid treatment to hemoglobin 
rich samples cannot be made as there were few cases to judge. However in 
general when preparing samples, those that appeared darker by eye (more 
hemoglobin) would often have larger precipitates after the addition of 0.1 
M sodium tetraborate and ultimately lead to poorer CZE separation. More 
experiments adjusting parameters and choosing samples in varying degrees 
of hemoglobin concentrations are necessary.  
 
CONCLUSIONS 
 
The distinctive lack of tools available to medical examiners and 
investigators to report on chronic alcohol abuse at death is unfortunate. 
Utilizing a capillary zone electrophoresis method to separate and detect 
%CDT in post-mortem blood samples allows the forensic community insight 
into ante-mortem habits. A study of 498 samples yielded 72 subjects with 
interpretable electropherograms. The study revealed no significant 
differences between races, genders, PMI, or BMI in general for an increase 
of %CDT. A significant correlation could be found in subjects with anatomo-
pathological signs of chronic alcohol abuse and increased %CDT as well as a 
higher frequency of persons involved in accidental deaths. This fact 
corroborates with the thought that alcoholics engage in riskier behaviors 
than normal persons.  
While not a large percentage of the total samples, the value of the 
information gained can be immeasurable. When an autopsy is not 
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performed, CDT can still be measured by taking a small sample of blood and 
could be helpful in determining cause and manner of death. In addition, 
further investigation into sample pretreatment options and decreasing PMI 
by having on site centrifugation or short travel times will only improve the 
rate of interpretable data. Capillary zone electrophoresis is a useful tool to 
determine %CDT in post-mortem samples. 
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